Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. - Enterprise Valueverified

PHIO

Price:

$0.9842

Market Cap:

$11.43M

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.

Industry

Biotechnology

IPO Date

2012-05-10

Stock Exchange

NASDAQ

Ticker

PHIO

The Enterprise Value as of July 2026 (TTM) for Phio Pharmaceuticals Corp. (PHIO) is -5597303.00

According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is -5597303.00. This represents a change of 168.43% compared to the average of -2085210.06 of the last 4 quarters.

Phio Pharmaceuticals Corp. (PHIO) Historical Enterprise Value (quarterly & annually)

How has PHIO Enterprise Value performed in the past?

The mean historical Enterprise Value of Phio Pharmaceuticals Corp. over the last ten years is -5813220.15. The current -5597303.00 Enterprise Value has changed 9.53% with respect to the historical average. Over the past ten years (40 quarters), PHIO's Enterprise Value was at its highest in in the June 2016 quarter at 11.83M. The Enterprise Value was at its lowest in in the December 2021 quarter at -10241048.00.

Quarterly (TTM)
Annual

Average

-5813220.15

Median

-6708445.69

Minimum

-14747782.15

Maximum

8.95M

Phio Pharmaceuticals Corp. (PHIO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Phio Pharmaceuticals Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 758.60%

Maximum Annual Enterprise Value = 8.95M

Minimum Annual Increase = -240.30%

Minimum Annual Enterprise Value = -14747782.15

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025-14747782.15271.99%
2024-3964561.20-42.33%
2023-6874960.005.09%
2022-6541931.38-40.22%
2021-10944128.00758.60%
2020-1274655.36-38.91%
2019-2086509.82-83.39%
2018-12559619.32-240.30%
20178.95M-210.65%
2016-8090026.35-140.82%

Phio Pharmaceuticals Corp. (PHIO) Average Enterprise Value

How has PHIO Enterprise Value performed in the past?

The current Enterprise Value of Phio Pharmaceuticals Corp. (PHIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-8529101.12

5-year avg

-8614672.55

10-year avg

-5813220.15

Phio Pharmaceuticals Corp. (PHIO) Enterprise Value vs. Peers

How is PHIO’s Enterprise Value compared to its peers?

Phio Pharmaceuticals Corp.’s Enterprise Value is greater than TransCode Therapeutics, Inc. (-7585393.00), less than Kiora Pharmaceuticals, Inc. (808.31K), greater than IN8bio, Inc. (-9326062.00), less than BioCardia, Inc. (3.95M), greater than Aprea Therapeutics, Inc. (-42433104.00), less than Marker Therapeutics, Inc. (-2930031.00), less than Damora Therapeutics, Inc. (1.21B), less than Creative Medical Technology Holdings, Inc. (-3923167.00), greater than Acurx Pharmaceuticals, Inc. (-7051694.00), less than Aptevo Therapeutics Inc. (5.17M),

Build a custom stock screener for Phio Pharmaceuticals Corp. (PHIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Phio Pharmaceuticals Corp. (PHIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Phio Pharmaceuticals Corp.'s Enterprise Value?

What is the highest Enterprise Value for Phio Pharmaceuticals Corp. (PHIO)?

What is the 3-year average Enterprise Value for Phio Pharmaceuticals Corp. (PHIO)?

What is the 5-year average Enterprise Value for Phio Pharmaceuticals Corp. (PHIO)?

How does the current Enterprise Value for Phio Pharmaceuticals Corp. (PHIO) compare to its historical average?